





COVID-19 and endocrine diseases 
A statement from the European Society of Endocrinology* 
 
Introduction 
Corona-virus disease 2019 (COVID-19) outbreak requires that endocrinologists from all over 
Europe move on, even more, to the first line of care of our patients, also in collaboration with 
other physicians such as those in internal medicine and emergency units. This will preserve the 
health status and prevent the adverse COVID-19-related outcomes in people affected by 
different endocrine diseases. People with diabetes in particular are among those in high-risk 
categories who can have serious illness if they get the virus, according to the data published so 
far from the Chinese researchers, but other endocrine diseases such as obesity, malnutrition 
and adrenal insufficiency may also be impacted by COVID-19. Therefore, the responsibilities of 
endocrinologists worldwide due to the current COVID-19 outbreak are not minor. 
 
In addition, endocrinologists, as any other healthcare worker under the current COVID-19 
outbreak, will need to self-protect from this viral disease, which is demonstrating to have a 
very high disseminating and devastating capacity. We urge Health Authorities to provide 
adequate protection to the whole workforce of health professionals and to consistently test 
for COVID-19 the exposed personnel. A decrease in the number of healthcare professionals 
available for active medical practice in case they contract the disease, as it is happening in 
certain countries, is itself a threat for the healthcare system and the well-being of our patients. 
 
The virus seems to have spread from infected animals and human-to-human transmission is 
now more than evident, with a high suspicion that non-symptomatic individuals act as the 
major vectors. It spreads like any other respiratory infectious disease, through contaminated 
air-droplets that come out of the mouth of infected persons when talking, coughing or 
sneezing. The virus can survive in the environment from a few hours to a few days, depending 
on surfaces and environmental conditions, and touching affected surfaces. The mouth, nose 
and ocular mucosa appears to be the major way of transmission.  
 
Symptoms of COVID-19 infection 
General symptoms are relatively non-specific and similar to other common viral infections 
targeting the respiratory system, and include fever, cough, myalgia and shortness of breath. 
The clinical spectrum of the virus ranges from mild disease with non-specific signs and 
symptoms of acute respiratory illness, to severe pneumonia with respiratory failure and septic 
shock. Possibly, an overreaction of the immune system leading to an autoimmune aggression 
of the lungs could be involved in the most severe cases of Acute Distress Respiratory 
Syndrome. There have also been reports of asymptomatic infection and research in this matter 
is currently ongoing worldwide to elucidate the real prevalence of the disease and the true 
relative mortality ratio. 
 
COVID-19 infection and diabetes mellitus 
Increased risk of morbidity and mortality in patients with diabetes regarding COVID-19 
infection  
Older adults and those with serious chronic medical conditions like heart disease, lung disease 
and diabetes are at the highest risk for complications from COVID-19 infection. 
Chronic hyperglycemia negatively affects immune function and increases the risk of morbidity 
and mortality due to any infection and is associated to organic complications. This is also the 
case for COVID-19 infection (Casqueiro et al). During the Influenza A (H1N1) pandemic, the 
presence of diabetes tripled the risk of hospitalization and quadrupled the risk of ICU 
admission once hospitalized. Among COVID-19 mortality cases in Wuhan, China, major 
associated comorbidities included hypertension (53.8%), diabetes (42.3%), previous heart 
disease (19.2%) and cerebral infarction (15.4%). Additionally, as for seasonal influenza, 
new data regarding COVID-19 indicate that the infection potentiates myocardial damage and 
identifies underlying heart disorders as a new risk factor for severe complications and 
worsening of prognosis (Chen et al). 
 
Among the confirmed COVID-19 cases in China by Feb 11, 2020, the overall mortality reported 
is 2.3%. This data refers mostly to hospitalized patients (Zhi et al; CDC). Among persons with no 
underlying medical conditions, the reported mortality in China is 0.9%.  
 
There is a lack of data regarding the number of non-symptomatic cases, as in most countries 
universal microbiological screening has not been performed. It is presumed that the 
prevalence of the infection is probably high or very high in the community, thus leading to an 
overestimation of the prevalence of case fatality. However, mortality is strongly increased with 
the presence of comorbid diseases, including previous cardiovascular disease (10.5%), diabetes 
(7.3%), chronic respiratory disease, hypertension and cancer, each at 6%. Among 60-year-old 
people and older, mortality has been reported to be 14.8% in those >80 years, 8% for those 
between 70-79 years and 3.6% in the group of 60-69 years. Compared to non-ICU patients, 
critically ill patients are older (median age 66 years vs. 51 years) and have more previous 
comorbidities (72% vs. 37%) (Wang et al). Worldwide mortality rates may vary by region, but 
this information is not yet consistently available and comparable, as public health policies 
applied and health registers used in every region of the world are not homogeneous.  
 
What people with diabetes should do to prevent infection by COVID-19 
Social distancing as well as home confinement of the whole population are now widely 
adopted in many countries in Europe and worldwide as measures hopefully effective in 
contrast to the spread of infection. We recommend that due to the increased dangers of 
developing COVID-19, persons with diabetes should strictly adhere to these preventive 
measures and adopt them also within their homes in order to avoid being in contact with their 
relatives. Therefore, under these circumstances, it is recommended that people with diabetes 
try to plan ahead of time what to do in case they get ill. It is important to maintain a good 
glycemic control, because it might help reduce the risk of infection itself and may also 
modulate the severity of the clinical expression of the disease. 
Contact with healthcare providers, such as endocrinologists in the case of type 1 diabetes, and 
including also internal medicine specialists and general practitioners for type 2 diabetes 
patients may be advisable. However, routine appointments in person are not recommended 
for people with diabetes, as they should avoid crowds (waiting rooms). Therefore, we 
recommend phone calls, video calls and emails as the main way for patients to keep in touch 
with their healthcare provider team, in order to guarantee an optimal control of the disease. 
Moreover, it is advised to ensure adequate stock of medications and supplies for monitoring 
blood glucose during the period of home confinement.  
What people with diabetes should do if they are infected by COVID-19 
People with diabetes who are infected with COVID-19 may experience a deterioration of 
glycemic control during the illness, like in any other infectious episodes. Implementation of 
“Sick day rules” is therefore mandatory to overcome potential diabetes decompensation. 
Contacting the healthcare provider team by telephone, email or videoconference is also 
mandatory in case of possible symptoms of COVID-19 infection in order to seek advice 
concerning the measures to avoid risk of deterioration of diabetes control or the possibility to 
be referred to another specialist (pneumologist or infectious disease doctor) or in the 
Emergency Services of the referral hospital to avoid the most serious systemic complication of 
the viral infection itself. 
COVID-19 and other endocrine and metabolic disorders 
Obesity 
There is a general lack of data regarding the impact of COVID-19 in people suffering from 
obesity. However, as for what is currently being the experience in some hospitals in Spain, 
cases of young people in which severe obesity is present may evolve towards destructive 
alveolitis with respiratory failure and death (Puig-Domingo M, personal experience). There is 
no current explanation for this clinical presentation, although it is well known that severe 
obesity is associated to sleep-apnea syndrome, as well as to surfactant dysfunction, which may 
contribute to a worse scenario in the case of COVID-19 infection. Also, deterioration of 
glycemic control is associated with an impairment of ventilatory function and thus may 
contribute to a worse prognosis in these patients. In addition, type 2 diabetes and obesity may 
concur in a given patient, which typically is also frequently accompanied by an age >65. In 






Regarding undernourished subjects, COVID-19 infection is associated to a high risk of 
malnutrition development, mostly related to increased requirements and the presence of a 
severe acute inflammatory status. These patients show also a hyporexic state, thus 
contributing to a negative nutritional balance. Estimated nutritional requirements are 25-30 
kcal/kg of weight and 1.5 g protein/kg/day (Jin et al). A nutrient dense diet is recommended in 
hospitalized cases including high protein supplements (2-3 intakes per day) containing at least 
18 grams of protein per intake. Adequate supplementation of vitamin D is recommended 
particularly in areas with large known prevalence of hypovitaminosis D and due to the 
decreased sun exposure. If nutritional requirements are not met, complementary or complete 
enteral feeding may be required and, in case that enteral feeding may not be possible due to 
inadequate gastrointestinal tolerance, the patient should be put on parenteral nutrition. 
COVID-19 patients' outcome is expected to improve with nutritional support. 
 
Adrenal insufficiency 
Adrenal insufficiency is a chronic condition of lack of cortisol production.  Live-long 
replacement treatment aiming to mimic physiologic plasma cortisol concentrations is not easy 
for these patients.  
Based on current data, there is no evidence that patients with adrenal insufficiency are at 
increased risk of contracting COVID-19. However, it is known that patients with Addison’s 
disease (primary adrenal insufficiency) and congenital adrenal hyperplasia have a slightly 
increased overall risk of catching infections. Moreover, primary adrenal insufficiency is 
associated to an impaired natural immunity function with a defective action of neutrophils and 
natural killer-cells (Bancos et al). This may explain, in part, this slightly increased rate of 
infectious diseases in these patients, as well as an overall increased mortality. This latter could 
also be accounted by an insufficient compensatory increase of the hydrocortisone dosage at 
the time of the beginning of an episode of infection. For all these reasons, patients with 
adrenal insufficiency may be at higher risk of medical complications and eventually at 
increased mortality risk in the case of COVID-19 infection. So far, there are no reported data 
on the outcomes of COVID-19 infection in adrenal insufficient subjects. 
 
In the case of suspicion of COVID-19, a prompt modification of the replacement treatment as 
indicated for the “Sick days” should be established when minor symptoms appear. This means 
in the first instance to at least double the usual doses of glucocorticoid replacement, to avoid 
adrenal crisis. Additionally, patients are also recommended to have sufficient stock at home of 
steroid pills and injections in order to maintain the social confinement that is required in most 
of the countries for impeding the COVID-19 outbreak spread. 
  
 
Actions to be taken if infection by COVID-19 is suspected 
If a person with endocrine and metabolic diseases has fever with cough or trouble breathing 
and may have been exposed to COVID-19 (if living in or visited a country affected in the 14 
days before getting sick, or if having been around a person who may have had the virus), a call 
to the physician or nurse for advice should be made. Some countries have set up COVID-19 
phone lines for the public. The personnel in charge of these phone lines will prioritize 
arrangements, if needed, regarding what should be the next step in the healthcare protocol. If 
the person is advised to go to the hospital, it is recommended to put on a face mask. In 
countries with explosive outbreak, most of the people have already bought a face mask by 
their own initiative. Fluid samples taken from the nose or throat will be used for microbiologic 
diagnosis. There is currently no specific treatment for COVID-19, but since the majority of 
cases are mild, only a limited amount of people will require hospitalization for supportive care. 
However, in most of the countries in which the outbreak has been declared and recognized, 
particularly in China, the Northern regions of Italy, Iran and Spain, the situation has been very 
challenging and the requirement of hospitalization has led national health systems to the limit 
of their capacities. 
 
What to do in case of confinement at home? 
Individuals and families affected or suspected to be affected by COVID-19 that stay at home 
should follow proper measures for infection prevention and control. Management should 
focus on prevention of transmission to others and monitoring for clinical deterioration, which 
may prompt hospitalization. Affected persons should be placed in a well-ventilated single 
room, while household members should stay in a different room or, if that is not possible, 
maintain a distance of at least one meter from the person affected (e.g. sleep in a separate 
bed) and perform hand hygiene (washing hands with soap and water) after any type of contact 
with the affected person or their immediate environment. When washing hands, it is 
preferable to use disposable paper towels to dry them. If these are not available, clean cloth 
towels should be used and replaced when wet. To contain respiratory secretions, a medical 
mask should be provided to the person affected and worn as much as possible. Individuals 
who cannot tolerate a medical mask should use rigorous respiratory hygiene − ie. the mouth 
and nose should be covered with a disposable paper tissue when coughing or sneezing. 
Caregivers should also wear a tightly fitted medical mask that cover their mouth and nose 






An ESE “decalogue” for endocrinologists in the COVID-19 pandemic 
1. Adequately protect yourself and ask for COVID-19 testing if exposed 
2. Avoid unnecessary routine appointments in person 
3. Put in place online/email/phone consultation services 
4. Closely monitor glycemic control in patients with diabetes 
5. Recommend to persons with diabetes a strict adherence to general preventive 
measures 
6. Counsel persons with diabetes about specific measures related to their disease 
management (sick day rules) in case of infection by COVID-19 
7. Counsel persons with diabetes particularly if aged over 65 and obese about 
referrals for management in case of suspected infection by COVID-19 
8. Avoid undernourishment with dietary or adjunctive measures if clinically indicated 
9. Closely monitor clinical conditions of patients with adrenal insufficiency 
10. Adapt increased replacement treatment if clinically indicated in patients with 
adrenal insufficiency 
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